Chase AIPricingFAQs
Display currency
Loading news…

Toltec Pharmaceuticals

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Chicago, Illinois, United States Founded 2006 1-10 employees For Profit

Toltec Pharmaceuticals is a biotechnology company developing therapeutics for the treatment of lower reproductive tract infection.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Patents
3

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private
Valuation range
$10M to $50M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Patents granted
3
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2006
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
1
HQ
Chicago, Illinois, United States
Region
Greater Chicago Area, Great Lakes, Midwestern US

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
3.2
Trend (90d)
2.6

Key People at Toltec Pharmaceuticals

Founder and Member of the Board of Directors

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Toltec Pharmaceuticals

Loading news…

FAQs about Toltec Pharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.
Toltec Pharmaceuticals - Company Profile, Full Acquisitions List, Funding and Investments